Startup challenges rival over brain monitoring tech at ITC

California medical device company sues rival at the ITC and in Delaware court over “copycat” brain monitoring system launch in May | Ceribell accuses competitor of “a history of willful patent infringement”.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

‘We created law’: G1/24 and the creation of the ‘diamond standard’

3 July 2025 The architect of an historic change in the way patent claims are interpreted explains what it means for AI drafting, and why more harmonisation may follow, reports Tom Phillips

Americas

WATCH: Policy direction—where are we now?

30 June 2025 This session brings together experts from Choate, Radius Health, and Syros Pharmaceuticals to examine the current policy landscape affecting life sciences patents. Discussions focus on recent developments such as the Inflation Reduction Act’s drug pricing provisions and concerns over patent examination quality at the USPTO.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Startup challenges rival over brain monitoring tech at ITC

More on this story

Editor's picks

Editor's picks

More features